HRP980646B1 - Novel oleandomycin derivatives - Google Patents

Novel oleandomycin derivatives

Info

Publication number
HRP980646B1
HRP980646B1 HR980646A HRP980646A HRP980646B1 HR P980646 B1 HRP980646 B1 HR P980646B1 HR 980646 A HR980646 A HR 980646A HR P980646 A HRP980646 A HR P980646A HR P980646 B1 HRP980646 B1 HR P980646B1
Authority
HR
Croatia
Prior art keywords
meaning
group
individual
ketone
hydrogen
Prior art date
Application number
HR980646A
Other languages
English (en)
Croatian (hr)
Inventor
Burek Gordana
Lazarevski Gorjana
Kobrehel Gabrijela
Original Assignee
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. filed Critical GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.
Priority to HR980646A priority Critical patent/HRP980646B1/xx
Priority to JP2000592297A priority patent/JP2002534432A/ja
Priority to SK918-2001A priority patent/SK9182001A3/sk
Priority to US09/869,606 priority patent/US6573367B1/en
Priority to PL99349638A priority patent/PL195977B1/pl
Priority to CA002358594A priority patent/CA2358594A1/en
Priority to ES99964758T priority patent/ES2280130T3/es
Priority to PCT/HR1999/000035 priority patent/WO2000040589A2/en
Priority to CZ20012316A priority patent/CZ20012316A3/cs
Priority to AU30679/00A priority patent/AU3067900A/en
Priority to HU0105049A priority patent/HUP0105049A3/hu
Priority to CNB998153036A priority patent/CN1147500C/zh
Priority to RU2001121147/04A priority patent/RU2234510C2/ru
Priority to EP99964758A priority patent/EP1140962B1/de
Priority to DE69935250T priority patent/DE69935250T2/de
Priority to AT99964758T priority patent/ATE354580T1/de
Publication of HRP980646A2 publication Critical patent/HRP980646A2/hr
Priority to HK02103276.7A priority patent/HK1043597B/zh
Publication of HRP980646B1 publication Critical patent/HRP980646B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR980646A 1998-12-30 1998-12-30 Novel oleandomycin derivatives HRP980646B1 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
HR980646A HRP980646B1 (en) 1998-12-30 1998-12-30 Novel oleandomycin derivatives
AU30679/00A AU3067900A (en) 1998-12-30 1999-12-29 Novel derivatives from the class of oleandomycin
HU0105049A HUP0105049A3 (en) 1998-12-30 1999-12-29 Novel derivatives from the class of oleandomycin, process for their preparation and their intermediates
US09/869,606 US6573367B1 (en) 1998-12-30 1999-12-29 Derivatives from the class of oleandomycin
PL99349638A PL195977B1 (pl) 1998-12-30 1999-12-29 Pochodne z klasy oleandomycyny i sposób wytwarzania pochodnych z klasy oleandomycyny
CA002358594A CA2358594A1 (en) 1998-12-30 1999-12-29 Novel derivatives from the class of oleandomycin
ES99964758T ES2280130T3 (es) 1998-12-30 1999-12-29 Nuevos derivados de la clase de la oleandomicina.
PCT/HR1999/000035 WO2000040589A2 (en) 1998-12-30 1999-12-29 Novel derivatives from the class of oleandomycin
CZ20012316A CZ20012316A3 (cs) 1998-12-30 1999-12-29 Nové deriváty ze třídy oleandomycinu
JP2000592297A JP2002534432A (ja) 1998-12-30 1999-12-29 オレアンドマイシンのクラスからの新規誘導体
SK918-2001A SK9182001A3 (en) 1998-12-30 1999-12-29 Novel derivatives from the class of oleandomycin
CNB998153036A CN1147500C (zh) 1998-12-30 1999-12-29 竹桃霉素类的新衍生物
RU2001121147/04A RU2234510C2 (ru) 1998-12-30 1999-12-29 Производные класса олеандомицина и способ их получения
EP99964758A EP1140962B1 (de) 1998-12-30 1999-12-29 Oleandomycin-derivate
DE69935250T DE69935250T2 (de) 1998-12-30 1999-12-29 Oleandomycin-derivate
AT99964758T ATE354580T1 (de) 1998-12-30 1999-12-29 Oleandomycin-derivate
HK02103276.7A HK1043597B (zh) 1998-12-30 2002-05-02 竹桃霉素類的新衍生物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR980646A HRP980646B1 (en) 1998-12-30 1998-12-30 Novel oleandomycin derivatives

Publications (2)

Publication Number Publication Date
HRP980646A2 HRP980646A2 (en) 2001-02-28
HRP980646B1 true HRP980646B1 (en) 2008-02-29

Family

ID=10946862

Family Applications (1)

Application Number Title Priority Date Filing Date
HR980646A HRP980646B1 (en) 1998-12-30 1998-12-30 Novel oleandomycin derivatives

Country Status (17)

Country Link
US (1) US6573367B1 (de)
EP (1) EP1140962B1 (de)
JP (1) JP2002534432A (de)
CN (1) CN1147500C (de)
AT (1) ATE354580T1 (de)
AU (1) AU3067900A (de)
CA (1) CA2358594A1 (de)
CZ (1) CZ20012316A3 (de)
DE (1) DE69935250T2 (de)
ES (1) ES2280130T3 (de)
HK (1) HK1043597B (de)
HR (1) HRP980646B1 (de)
HU (1) HUP0105049A3 (de)
PL (1) PL195977B1 (de)
RU (1) RU2234510C2 (de)
SK (1) SK9182001A3 (de)
WO (1) WO2000040589A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
EP2716647A3 (de) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Makrocyclische Verbindungen Und Verfahren Zu Deren Herstellung Und Anwendung
EP1934237A2 (de) 2005-08-24 2008-06-25 Rib-X Pharmaceuticals, Inc. Triazolverbindungen und verfahren zu deren herstellung und anwendung
EP1928893A2 (de) 2005-08-24 2008-06-11 Rib-X Pharmaceuticals, Inc. Triazolverbindungen und verfahren zu ihrer herstellung und verwendung
ATE468119T1 (de) 2006-06-12 2010-06-15 Univ Ramot Verfahren zur behandlung von krebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2757123A (en) * 1955-06-29 1956-07-31 Pfizer & Co C Oleandomycin, its salts and production
US3144466A (en) * 1963-03-08 1964-08-11 Pfizer & Co C Diacyl esters of de-oleandrosehydroxyoleandomycin and process therefor
LU87039A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters biaromatiques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
RU2052263C1 (ru) * 1993-10-21 1996-01-20 Товарищество с ограниченной ответственностью "НИТА" Средство "бентокомплекс" для профилактики и лечения эндометрита у коров

Also Published As

Publication number Publication date
CA2358594A1 (en) 2000-07-13
CN1332746A (zh) 2002-01-23
HK1043597A1 (en) 2002-09-20
HUP0105049A3 (en) 2003-10-28
ATE354580T1 (de) 2007-03-15
EP1140962B1 (de) 2007-02-21
PL195977B1 (pl) 2007-11-30
EP1140962A2 (de) 2001-10-10
WO2000040589A3 (en) 2000-11-23
HRP980646A2 (en) 2001-02-28
HK1043597B (zh) 2004-10-08
AU3067900A (en) 2000-07-24
JP2002534432A (ja) 2002-10-15
ES2280130T3 (es) 2007-09-01
RU2234510C2 (ru) 2004-08-20
SK9182001A3 (en) 2002-01-07
CN1147500C (zh) 2004-04-28
US6573367B1 (en) 2003-06-03
WO2000040589A2 (en) 2000-07-13
DE69935250D1 (de) 2007-04-05
CZ20012316A3 (cs) 2001-10-17
DE69935250T2 (de) 2007-10-31
HUP0105049A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
EP0758653A4 (de) Imidazolchinazolinderivate
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
NO20012288D0 (no) Gastrin og cholecystokinin reseptor ligander
MX9606331A (es) Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor.
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
AU9281198A (en) Benzofuran derivatives
HRP20000585B1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
ES2188984T3 (es) Procedimiento de enriquecimiento en r de epimeros de derivados de 16,17-acetales de derivados de 21-aciloxi-pregnano-1,4-dieno-11-beta, 16alfa-triol-3,20-dionas.
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
NO981393D0 (no) Guanidinoproteasehemmere
HRP980646B1 (en) Novel oleandomycin derivatives
ATE222455T1 (de) Fungizide salze
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
MX207081B (de)
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
SE0003186D0 (sv) New process
DE69706950T2 (de) Furoindolizine
EP0967212A4 (de) Pyrazolin-verbindungen und ihre anwendung als mittel zur kontrolle von pflanzenkrankheiten
EP0657443A4 (de) Optisch aktive carboxamidderivate.
ATE259800T1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
NO994104L (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: PLIVA-ISTRAZIVACKI INSTITUT D.O.O., HR

PNAN Change of the applicant name, address/residence

Owner name: GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O.,

ODRP Renewal fee for the maintenance of a patent

Payment date: 20080206

Year of fee payment: 9

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20081231